Percutaneous absorption in experimental epidermal disease.
Little is known about the absorption of topical drugs in epidermal disease associated with epidermal proliferation and altered keratinization. An abnormal hairless mouse epidermis was produced by three different methods: ultraviolet light irradiation, topical vitamin A acid and topical acetic acid. An increased epidermal thickness resulted and the in vitro percutaneous absorption of 0.1% (4-14C) hydrocortisone was found to be increased when compared with normal hairless mouse epidermis. This is evidence for defective skin barrier function in experimental epidermal disease.
D000818:Animals; D001699:Biometry; D004817:Epidermis / Q000378:metabolism / Q000473:pathology; D005260:Female; D006854:Hydrocortisone / Q000378:metabolism; D051379:Mice; D012867:Skin / Q000473:pathology; D012869:Skin Absorption; D012871:Skin Diseases / Q000378:metabolism* / Q000473:pathology
D006854:Hydrocortisone